Andrew R. Galazka

机构：Merck KGaA, Darmstadt (Germany)

发表论文 77 篇 · 总被引 1516 次 · h-index 20

代表论文

• Pharmacokinetics and Pharmacodynamics of Recombinant Human Interferon-β in Healthy Male Volunteers (1996 · Journal of Interferon & Cytokine Research · 被引 166)
• Effect of cladribine tablets on lymphocyte reduction and repopulation dynamics in patients with relapsing multiple sclerosis (2019 · Multiple Sclerosis and Related Disorders · 被引 146)
• Safety of cladribine tablets in the treatment of patients with multiple sclerosis: An integrated analysis (2018 · Multiple Sclerosis and Related Disorders · 被引 124)
• Long-term safety data from the cladribine tablets clinical development program in multiple sclerosis (2020 · Multiple Sclerosis and Related Disorders · 被引 73)
• Intraperitoneal recombinant gamma-interferon in patients with recurrent ascitic ovarian carcinoma: modulation of cytotoxicity and cytokine production in tumor-associated effectors and of major histocompatibility antigen expression on tumor cells. (1990 · PubMed · 被引 73)
• The clinical effects of prolonged treatment of patients with advanced cancer with low-dose subcutaneous interleukin-2 (1991 · British Journal of Cancer · 被引 69)